Cell-free Assays (IC50/Ki) for Bulevirtide (Myrcludex B)
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| No published data available. | |||
Cell-based Assay (IC50) for Bulevirtide (Myrcludex B)
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| primary human hepatocytes | 52.5 nM (bile acid transport), 669 pM (HBsAg), 83 pM (HBeAg) | Bile acid transport inhibition, HBV infection (HBsAg/HBeAg detection) | PMC7001544 |
| HepNB2.7 | 1.4 nM | In-cell ELISA assay | Download PDF |
| HepNB2.7 | 1.2 nM | In-cell ELISA assay | Download PDF |
| HuH7-NTCP | 1.5 nM | In-cell ELISA assay | Download PDF |
| primary human hepatocytes | 52.5 nM (bile acid transport), 669 pM (HBsAg), 83 pM (HBeAg) | Bile acid transport inhibition, HBV infection (HBsAg/HBeAg detection) | PMC7001544 |
| HepNB2.7 | 1.4 nM | In-cell ELISA assay | Download PDF |
| HepNB2.7 | 1.2 nM | In-cell ELISA assay | Download PDF |
| HuH7-NTCP | 1.5 nM | In-cell ELISA assay | Download PDF |
Check the
Bulevirtide (Myrcludex B)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Bulevirtide (Myrcludex B) Mechanism of Action: NTCP Inhibition in Hepatocyte Research
- Bulevirtide (Myrcludex B) Clinical Trials
- Bulevirtide (Myrcludex B) Working Concentration | Cell Culture | Treatment
- Bulevirtide (Myrcludex B) Solubility in DMSO
- Bulevirtide (Myrcludex B) Stock Solution
- Bulevirtide (Myrcludex B) Storage
- Bulevirtide (Myrcludex B) Stability
- Bulevirtide (Myrcludex B) Combination Database
- Bulevirtide (Myrcludex B) Molecular Weight
- Bulevirtide (Myrcludex B) CAS Number
- Bulevirtide (Myrcludex B) Chemical Structure (2D and 3D)
- Bulevirtide (Myrcludex B) Sigma (aabh9a95bc91)? Try a better option.
- Bulevirtide (Myrcludex B) MedChemExpress (HY-P3465)? Try a better option.
- Bulevirtide (Myrcludex B) APExBIO (BA1813)? Try a better option.
- Bulevirtide (Myrcludex B) SDS｜MSDS